Drug-Pricing Bill Threatens Robust Generics Industry
The Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019, or BLOCKING Act, was introduced in the U.S. House by of Representatives by Rep. Kurt Schrader,...To view the full article, register now.
Already a subscriber? Click here to view full article